Breakthrough in Muscular Dystrophy Treatment: FDA Approves Stem Cell Therapy from Myogenica
The fight against muscular dystrophy has taken a promising turn with the recent FDA approval of an Investigational New Drug (IND) application for MyoPAXon, a revolutionary stem cell-derived muscle stem cell product developed by Myogenica, a University of Minnesota startup. This landmark approval paves the way for a clinical trial aimed at treating patients with […]
$500,000 Awarded for Groundbreaking Duchenne Muscular Dystrophy Trial
In a landmark announcement, Duchenne UK and Parent Project Muscular Dystrophy (PPMD) have committed $500,000 to a pioneering Phase 1 clinical trial aimed at evaluating the safety and tolerability of muscle progenitor cells in patients with Duchenne Muscular Dystrophy (DMD). This trial represents a significant advancement in the quest to find effective treatments for this […]
Global Stem Cells Market to Generate Revenue of $25.68 Billion By 2028 | More than 80% of Revenue Comes from Adult Stem Cells
Westford,USA, Nov. 02, 2022 (GLOBE NEWSWIRE) — The demand for stem cells market is growing rapidly as the potential for their use in medical treatments expands. In particular, there is great interest in using stem cells to treat a range of degenerative diseases and injuries, as well as to improve the success of organ transplants. Recent advances […]